Envisioning a Transformed Clinical Trials Enterprise For 2030
Envisioning a Transformed Clinical Trials Enterprise For 2030
Forum on Drug Discovery, Development, and Translation, National Academies of Sciences, Engineering, and Medicine, Carolyn Shore, Health and Medicine Division, Board on Health Sciences Policy
Details
- OL Work ID
- OL26993375W